加拿大科技公司Zentek计划在一年内通过正常发行人出价购买其高达5%的股份。 Canadian tech firm Zentek plans a Normal Course Issuer Bid to buy up to 5% of its shares over a year.
加拿大知识产权技术公司Zentek Ltd.计划通过普通交易方式发行人投标 (NCIB) 购买多达5,084,319股普通股,约合合500万美元. Zentek Ltd., a Canadian IP tech firm, plans a Normal Course Issuer Bid (NCIB) to buy up to 5,084,319 common shares, approx. 其发行和未清股份的5%,超过一年。 5% of its issued & outstanding shares, over a year. 购买将在TSX风险交易所上进行,每30天最多为2%。 The purchases will be made on the TSX Venture Exchange, with a max of 2% per 30-day period. Zentek的董事会认为其股票价格可能不能充分反映其商业价值。 Zentek's board believes its stock price might not fully reflect its business value. Integral Wealth Securities Limited被任命为NCIB的经纪人，该交易可能持续至2025年8月15日。 Integral Wealth Securities Limited is appointed as the broker for the NCIB, which may run until August 15, 2025. Zentek的ZenGUARD技术平台显示99%的抗微生物活动,外科口罩的病毒过滤效率提高,有可能加强HVAC系统。 Zentek's ZenGUARD tech platform shows 99% anti-microbial activity and increased viral filtration efficiency for surgical masks, potentially enhancing HVAC systems.